GLP-1 Plus Integrated Care Support Beats GLP-1 Alone by Over 60% in Two-Year Real-World Study
BOSTON, Nov. 16, 2026
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.

![]()
GLP-1 Plus Integrated Care Support Beats GLP-1 Alone by Over 60% in Two-Year Real-World Study
PR Newswire
BOSTON, Nov. 16, 2026
A two-year, real-world study of nearly 5,000 people starting a GLP-1 shows what a comprehensive metabolic health program adds on top of the medication alone: more weight loss, more weight kept off over two years, and a healthier body composition.
BOSTON, Nov. 16, 2026 /PRNewswire/ — Withings Health Solutions and Calibrate Health today released results from a joint real-world study that tackles one of the biggest open questions in obesity care: what does a comprehensive support program add on top of a GLP-1?
The answer is a lot. People who started a GLP-1 with Calibrate’s program including close clinical oversight and an integrated behavior change program lost 17.3% of their starting weight after two years, compared with 10.7% for similar patients on the medication alone. That is over 60% more sustained weight loss.
As GLP-1 spending climbs, employers, payers and PBMs want to know what turns a prescription into lasting results. Most evidence on weight programs is relatively narrow and short-term. This study goes further: daily weigh-ins on Withings connected scales let researchers follow each person’s full weight journey for two years, from the first drop to the low point and any rebound that occurred.
It also compares like with like. Once the two groups were adjusted on 10 characteristics, from age and BMI to drug brand, the Calibrate program advantage held, and two different analysis methods reached the same answer.
Three key takeaways
- Over 60% more weight loss, and it lasts. Calibrate members lost on average 17.3% of their starting weight at two years, versus 10.7% on a GLP-1 alone, after adjusting for differences between the groups.
- Calibrate members keep more of their weight loss. As expected from a typical weight loss journey over two years, both groups regained some weight after their lowest point. But Calibrate members maintain a consistently lower weight. Even with the observed weight regain, Calibrate members remained 16.6% below their starting weight. This is much lower than the GLP-1 alone group at its best (12.6% weight loss) and substantially lower than the GLP-1 alone group lost at the peak of their weight rebound (9.2%).
- A healthier muscle-to-fat ratio, not just lower weight. Body composition readings from the same scales show Calibrate members’ muscle-to-fat ratio improved about 9 points more than those on a GLP-1 alone after 18 months (+49.3% vs +39.9% from its starting value). A program that only tracks weight would miss this important difference.
“GLP-1s are powerful, but a prescription alone isn’t a care plan. What this study shows is that clinical oversight and wraparound support turns health benefits spend into far greater weight loss. What’s more is that members hold that weight loss advantage even as some weight may naturally return. Because we can now see what’s happening beyond the scale, we also know to continue our focus on muscle mass preservation via a protein-forward eating plan and strength training as members lose weight,” said Rob Rebak, CEO, Calibrate.
“Effective GLP-1 care takes three things: the drug, a comprehensive care program and data” said Antoine Pivron, Vice President, Withings Health Solutions. “Our study with Calibrate shows what happens when you have all three: over 60% more weight loss at two years, and an advantage that holds even as some weight returns. As the industry moves toward paying for outcomes, this is the standard of evidence every GLP-1 program should be held to.”
About the study
The study analyzed real-world data from 4,961 U.S. adults who started a GLP-1 between 2022 and 2024 and were followed for two years: 3,422 Calibrate members and 1,539 Withings users on a GLP-1 alone. Body composition was analyzed over 18 months in a subgroup of 974 participants who started a GLP-1 in 2024 or later. The groups were adjusted for differences in profile and health using causal inference methods. Like any real-world study, it cannot account for factors that were not measured, such as motivation or income. Read the full study.
About Calibrate Health
Calibrate Health is the first digitally integrated obesity management solution, proven to deliver multi-year weight loss and cardiometabolic improvement. Its personalized model unifies clinical care and coaching, adapting to each member as an individual and translating their “why” into healthy habits that last a lifetime.
Backed by more than five years of real-world clinical data, Calibrate members achieve sustained outcomes that exceed results from medication alone. Across diverse employer populations, the program has reduced GLP-1 spend while driving long-term weight loss and improving metabolic health.
Calibrate partners with employers ranging from several thousand to several hundred thousand employees across multiple industries and works with all major PBMs. For more information, visit www.calibratehealth.com.
About Withings Health Solutions
Withings Health Solutions is a dedicated division of global connected health leader Withings, serving healthcare professionals across chronic disease prevention and management, remote patient monitoring, clinical research, and more. Its mission is to bridge the gap between patients and their care teams by continuously and effortlessly providing healthcare professionals with medical-grade data generated by patients from an ecosystem of connected devices. For more than a decade, Withings has built an expertise in user experience, engagement and retention. Withings Health Solutions extends this expertise to the healthcare industry to remove friction in the patient’s journey and allow for digital health to expand. For more information, visit withings.com/us/en/health-solutions.
Media contacts
Withings: Kate Kaminsky, withings@12080group.com
Calibrate: Michelle Mirchandani, michelle.mirchandani@joincalibrate.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/glp-1-plus-integrated-care-support-beats-glp-1-alone-by-over-60-in-two-year-real-world-study-302939371.html
SOURCE Withings Health Solutions

